Antibiotic administration and the development of obesity in children

Nicola Principi, Susanna Esposito

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Antibiotics are the most common prescription drugs administered at the paediatric age, however their administration can cause unwanted problems. Among these issues, antibiotic-induced gut microbiota dysbiosis has appeared as an emerging issue and has been associated with obesity. This problem is particularly relevant in children because they are frequently treated with antibiotics. Early development of obesity increases the risk of adult obesity, which is associated with the emergence of very severe clinical problems. Dysbiosis induced in the first periods of life can have the most relevant practical consequences because a decrease in the number of microbes and their substitution with other microbes dramatically modifies the development of the immune system as well as glucose and lipid metabolism. Unfortunately, not all of the mechanisms that could explain the relationship between gut microbiota modification and the development of obesity have been defined. Consequently, no definitive therapeutic approach has been elucidated. Probiotics and prebiotics could play a role in treating microbial dysbiosis because the addition of specific bacterial strains has been associated with normal weight and has been demonstrated to be useful in clinical conditions other than obesity that are caused by microbiota disruption. Considering that antibiotics are commonly prescribed and that obesity is increasing in paediatric patients, further studies specifically designed to evaluate how to disrupt the relationship between antibiotics and dysbiosis are urgently needed. Presently, paediatricians have to consider dysbiosis to be a new and serious reason for the judicious use of antibiotics in clinical practice.

Original languageEnglish
Pages (from-to)171-177
Number of pages7
JournalInternational Journal of Antimicrobial Agents
Volume47
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Dysbiosis
Pediatric Obesity
Obesity
Anti-Bacterial Agents
Pediatrics
Prebiotics
Prescription Drugs
Microbiota
Probiotics
Lipid Metabolism
Immune System
Weights and Measures
Glucose

Keywords

  • Anti-infective therapy
  • Antibiotic
  • Obesity
  • Overweight
  • Prebiotics
  • Probiotics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Antibiotic administration and the development of obesity in children. / Principi, Nicola; Esposito, Susanna.

In: International Journal of Antimicrobial Agents, Vol. 47, No. 3, 01.03.2016, p. 171-177.

Research output: Contribution to journalArticle

Principi, Nicola ; Esposito, Susanna. / Antibiotic administration and the development of obesity in children. In: International Journal of Antimicrobial Agents. 2016 ; Vol. 47, No. 3. pp. 171-177.
@article{175d3ee35edd4d38ab90a08c0f1d3c29,
title = "Antibiotic administration and the development of obesity in children",
abstract = "Antibiotics are the most common prescription drugs administered at the paediatric age, however their administration can cause unwanted problems. Among these issues, antibiotic-induced gut microbiota dysbiosis has appeared as an emerging issue and has been associated with obesity. This problem is particularly relevant in children because they are frequently treated with antibiotics. Early development of obesity increases the risk of adult obesity, which is associated with the emergence of very severe clinical problems. Dysbiosis induced in the first periods of life can have the most relevant practical consequences because a decrease in the number of microbes and their substitution with other microbes dramatically modifies the development of the immune system as well as glucose and lipid metabolism. Unfortunately, not all of the mechanisms that could explain the relationship between gut microbiota modification and the development of obesity have been defined. Consequently, no definitive therapeutic approach has been elucidated. Probiotics and prebiotics could play a role in treating microbial dysbiosis because the addition of specific bacterial strains has been associated with normal weight and has been demonstrated to be useful in clinical conditions other than obesity that are caused by microbiota disruption. Considering that antibiotics are commonly prescribed and that obesity is increasing in paediatric patients, further studies specifically designed to evaluate how to disrupt the relationship between antibiotics and dysbiosis are urgently needed. Presently, paediatricians have to consider dysbiosis to be a new and serious reason for the judicious use of antibiotics in clinical practice.",
keywords = "Anti-infective therapy, Antibiotic, Obesity, Overweight, Prebiotics, Probiotics",
author = "Nicola Principi and Susanna Esposito",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.ijantimicag.2015.12.017",
language = "English",
volume = "47",
pages = "171--177",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Antibiotic administration and the development of obesity in children

AU - Principi, Nicola

AU - Esposito, Susanna

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Antibiotics are the most common prescription drugs administered at the paediatric age, however their administration can cause unwanted problems. Among these issues, antibiotic-induced gut microbiota dysbiosis has appeared as an emerging issue and has been associated with obesity. This problem is particularly relevant in children because they are frequently treated with antibiotics. Early development of obesity increases the risk of adult obesity, which is associated with the emergence of very severe clinical problems. Dysbiosis induced in the first periods of life can have the most relevant practical consequences because a decrease in the number of microbes and their substitution with other microbes dramatically modifies the development of the immune system as well as glucose and lipid metabolism. Unfortunately, not all of the mechanisms that could explain the relationship between gut microbiota modification and the development of obesity have been defined. Consequently, no definitive therapeutic approach has been elucidated. Probiotics and prebiotics could play a role in treating microbial dysbiosis because the addition of specific bacterial strains has been associated with normal weight and has been demonstrated to be useful in clinical conditions other than obesity that are caused by microbiota disruption. Considering that antibiotics are commonly prescribed and that obesity is increasing in paediatric patients, further studies specifically designed to evaluate how to disrupt the relationship between antibiotics and dysbiosis are urgently needed. Presently, paediatricians have to consider dysbiosis to be a new and serious reason for the judicious use of antibiotics in clinical practice.

AB - Antibiotics are the most common prescription drugs administered at the paediatric age, however their administration can cause unwanted problems. Among these issues, antibiotic-induced gut microbiota dysbiosis has appeared as an emerging issue and has been associated with obesity. This problem is particularly relevant in children because they are frequently treated with antibiotics. Early development of obesity increases the risk of adult obesity, which is associated with the emergence of very severe clinical problems. Dysbiosis induced in the first periods of life can have the most relevant practical consequences because a decrease in the number of microbes and their substitution with other microbes dramatically modifies the development of the immune system as well as glucose and lipid metabolism. Unfortunately, not all of the mechanisms that could explain the relationship between gut microbiota modification and the development of obesity have been defined. Consequently, no definitive therapeutic approach has been elucidated. Probiotics and prebiotics could play a role in treating microbial dysbiosis because the addition of specific bacterial strains has been associated with normal weight and has been demonstrated to be useful in clinical conditions other than obesity that are caused by microbiota disruption. Considering that antibiotics are commonly prescribed and that obesity is increasing in paediatric patients, further studies specifically designed to evaluate how to disrupt the relationship between antibiotics and dysbiosis are urgently needed. Presently, paediatricians have to consider dysbiosis to be a new and serious reason for the judicious use of antibiotics in clinical practice.

KW - Anti-infective therapy

KW - Antibiotic

KW - Obesity

KW - Overweight

KW - Prebiotics

KW - Probiotics

UR - http://www.scopus.com/inward/record.url?scp=84960272061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960272061&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2015.12.017

DO - 10.1016/j.ijantimicag.2015.12.017

M3 - Article

VL - 47

SP - 171

EP - 177

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 3

ER -